# BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
> **ANDA212082** · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT CO INC · Approved 2019-12-17
## Drug
- **FDA Application Number:** ANDA212082
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
- **Generic name:** BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES
- **Active ingredients:** ACETAMINOPHEN; BUTALBITAL; CAFFEINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LANNETT CO INC
- **Manufacturer:** Lannett Company, Inc.
- **First approval:** 2019-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212082)
---
*AI Analytics · CC0 1.0*